TipRanks on MSN

EssilorLuxottica’s myopia control study: A potential market game-changer

Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilorluxottica is currently conducting a clinical study ...
American Council on Science and HealthOpinion

Stop Sidelining Methadone: Make Primary Care an Option Again By Jeffrey A. Singer

American primary-care doctors can prescribe methadone for pain—but not for addiction. Meanwhile, their counterparts in ...
TipRanks on MSN

Almirall’s phase 1 study on LAD191: A potential game-changer in autoimmune treatment

Almirall SA ($GB:0O9B) announced an update on their ongoing clinical study. Almirall SA has recently completed a Phase 1 clinical study titled A ...
BioSpace

CAR-T Developers Will Need Randomized Trials as FDA Eyes Tighter Approval Requirements

For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
Ophthalmology Times

FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD

Azura Ophthalmics announced it has received positive feedback from a pre-New Drug Application (NDA) meeting with the US Food ...
Healthline

Types of Medical Studies: Your Guide

Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...